Literature DB >> 9931005

Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1.

L S Mizoue1, J F Bazan, E C Johnson, T M Handel.   

Abstract

Fractalkine, a novel CX3C chemokine, is unusual because of both its membrane-associated structure and its direct role in cell adhesion. We have solved the solution structure of the chemokine domain of fractalkine (residues 1-76) by heteronuclear NMR methods. The 20 lowest energy structures in the ensemble have an average backbone rmsd of 0.43 A, excluding the termini. In contrast to many other chemokines which form homodimers, fractalkine's chemokine module is monomeric. Comparison of the structure to CC and CXC chemokines reveals interesting differences which are likely to be relevant to receptor binding. These include a bulge formed by the CX3C motif, the relative orientation of the N-terminus and 30's loop (residues 30-38), and the conformation of the N-loop (residues 9-19). 15N backbone relaxation experiments indicate that these same regions of the protein are dynamic. We also titrated 15N-labeled protein with a peptide from the N-terminus of the receptor CX3CR1 and confirmed that this region of the receptor contacts the fractalkine chemokine domain. Interestingly, the binding site maps roughly to the regions of greatest flexibility and structural variability. Together, these data provide a first glimpse of how fractalkine interacts with its receptor and should help guide mutagenesis studies to further elucidate the molecular details of binding and signaling through CX3CR1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9931005     DOI: 10.1021/bi9820614

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  49 in total

1.  Rotamer strain as a determinant of protein structural specificity.

Authors:  G A Lazar; E C Johnson; J R Desjarlais; T M Handel
Journal:  Protein Sci       Date:  1999-12       Impact factor: 6.725

2.  The Tim9p-Tim10p complex binds to the transmembrane domains of the ADP/ATP carrier.

Authors:  Sean P Curran; Danielle Leuenberger; Wolfgang Oppliger; Carla M Koehler
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

Review 3.  Microglia in Health and Disease.

Authors:  Richard M Ransohoff; Joseph El Khoury
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-09-09       Impact factor: 10.005

4.  The solution structure of the anti-HIV chemokine vMIP-II.

Authors:  A C Liwang; Z X Wang; Y Sun; S C Peiper; P J Liwang
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

5.  Respiratory syncytial virus(RSV)-induced allergy may be controlled by IL-4 and CX3C fractalkine antagonists and CpG ODN as adjuvant: hypothesis and implications for treatment.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

Review 6.  Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivity.

Authors:  Lavanya Rajagopalan; Krishna Rajarathnam
Journal:  Biosci Rep       Date:  2006-10       Impact factor: 3.840

7.  Backbone dynamics of SDF-1alpha determined by NMR: interpretation in the presence of monomer-dimer equilibrium.

Authors:  Olga K Baryshnikova; Brian D Sykes
Journal:  Protein Sci       Date:  2006-11       Impact factor: 6.725

Review 8.  The chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity.

Authors:  R Colobran; R Pujol-Borrell; M P Armengol; M Juan
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

9.  Monomeric solution structure of the prototypical 'C' chemokine lymphotactin.

Authors:  E S Kuloglu; D R McCaslin; M Kitabwalla; C D Pauza; J L Markley; B F Volkman
Journal:  Biochemistry       Date:  2001-10-23       Impact factor: 3.162

10.  On-column refolding of recombinant chemokines for NMR studies and biological assays.

Authors:  Christopher T Veldkamp; Francis C Peterson; Paulette L Hayes; Jessie E Mattmiller; John C Haugner; Norberto de la Cruz; Brian F Volkman
Journal:  Protein Expr Purif       Date:  2006-09-24       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.